共查询到20条相似文献，搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Conclusions Rosiglitazone was effective in reducing glycemia as monotherapy and had no sign of sustained hepatotoxicity. It had beneficial effects on the urinary albumin excretion (ACR) and reduced levels of insulin and its precursors. 相似文献
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.